Mesa Laboratories Q3 Adjusted EPS $2.02 May Not Be Comparable To $0.19 Estimate, Sales $53.47M Miss $54.89M Estimate
Portfolio Pulse from Benzinga Newsdesk
Mesa Laboratories (NASDAQ:MLAB) reported Q3 earnings of $2.02 per share, significantly beating the $0.19 estimate but marking a 14.04% decrease from last year. Sales were $53.47M, missing the $54.89M estimate and showing a 1.50% decrease from the previous year.
February 05, 2024 | 1:02 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Mesa Laboratories reported a significant beat on EPS estimates but missed on sales forecasts, with both earnings and sales showing a year-over-year decrease.
The substantial beat on EPS estimates could be seen positively by investors, potentially offsetting concerns about the sales miss and year-over-year declines. The mixed results make the short-term impact on the stock price uncertain, hence a neutral score.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100